OrthoPediatrics (NASDAQ:KIDS – Get Free Report) and MariMed (OTCMKTS:MRMD – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership.
Profitability
This table compares OrthoPediatrics and MariMed’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| OrthoPediatrics | -12.83% | -8.10% | -5.46% |
| MariMed | -9.13% | -10.71% | -2.58% |
Earnings & Valuation
This table compares OrthoPediatrics and MariMed”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| OrthoPediatrics | $264.13 million | 3.25 | -$39.65 million | ($1.43) | -22.99 |
| MariMed | $159.83 million | 0.15 | -$14.48 million | ($0.04) | -1.51 |
MariMed has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than MariMed, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
OrthoPediatrics has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, MariMed has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.
Insider and Institutional Ownership
69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 0.2% of MariMed shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by company insiders. Comparatively, 16.0% of MariMed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for OrthoPediatrics and MariMed, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| OrthoPediatrics | 1 | 1 | 7 | 0 | 2.67 |
| MariMed | 0 | 2 | 0 | 0 | 2.00 |
OrthoPediatrics currently has a consensus target price of $30.75, suggesting a potential downside of 6.48%. Given OrthoPediatrics’ stronger consensus rating and higher possible upside, equities analysts plainly believe OrthoPediatrics is more favorable than MariMed.
Summary
OrthoPediatrics beats MariMed on 8 of the 14 factors compared between the two stocks.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
